Literature DB >> 25157885

In vivo proton magnetic resonance spectroscopy for the evaluation of hepatic encephalopathy in dogs.

Inés Carrera1, Patrick R Kircher, Dieter Meier, Henning Richter, Katrin Beckman, Matthias Dennler.   

Abstract

OBJECTIVE: To investigate clinical use of proton magnetic resonance spectroscopy ((1)H MRS) and to compare metabolic brain bioprofiles of dogs with and without hepatic encephalopathy. ANIMALS: 6 dogs with hepatic encephalopathy and 12 control dogs. PROCEDURES: Conventional MRI and single-voxel (1)H MRS were performed with a 3-T magnet. Images for routine MRI planes and sequences were obtained. Single-voxel (1)H MRS was performed with a point-resolved sequence with a short echo time (35 milliseconds) and voxel of interest placement at the level of the basal ganglia. Metabolites of interest included the glutamine-glutamate complex (sum quantification of glutamate and glutamine), myoinositol, N-acetyl aspartate, total choline, and creatine. Data were analyzed with postprocessing fitting algorithm software, and metabolite concentration relative to water and ratios with creatine as the reference metabolite were calculated.
RESULTS: Compared with control dogs, dogs with hepatic encephalopathy had specific changes, which included significantly higher concentration relative to water of the glutamine-glutamate complex and significantly lower concentration of myoinositol. Choline and N-acetyl aspartate concentrations were also slightly lower in dogs with hepatic encephalopathy than in control dogs. No differences in creatine concentration were detected between groups. CONCLUSIONS AND CLINICAL RELEVANCE: (1)H MRS aided in the diagnosis of hepatic encephalopathy in dogs, and findings supported the assumption that ammonia is a neurotoxin that manifests via glutamine-glutamate complex derangements. Use of (1)H MRS may provide clinically relevant information in patients with subclinical hepatic encephalopathy, equivocal results of bile acids tests, and equivocal ammonia concentrations or may be helpful in monitoring efficacy of medical management.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25157885     DOI: 10.2460/ajvr.75.9.818

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  6 in total

1.  Effects of Ethanol Exposure on the Neurochemical Profile of a Transgenic Mouse Model with Enhanced Glutamate Release Using In Vivo 1H MRS.

Authors:  Wen-Tung Wang; Phil Lee; Dongwei Hui; Elias K Michaelis; In-Young Choi
Journal:  Neurochem Res       Date:  2018-10-17       Impact factor: 3.996

2.  Effects of isoflurane, sevoflurane, propofol and alfaxalone on brain metabolism in dogs assessed by proton magnetic resonance spectroscopy (1H MRS).

Authors:  Franz Josef Söbbeler; Inés Carrera; Kirby Pasloske; Millagahamada Gedara Ranasinghe; Patrick Kircher; Sabine Beate Rita Kästner
Journal:  BMC Vet Res       Date:  2018-03-05       Impact factor: 2.741

3.  Astrocyte lesions in cerebral cortex and cerebellum of dogs with congenital ortosystemic shunting.

Authors:  Alun Williams; Adam Gow; Scott Kilpatrick; Mickey Tivers; Vicky Lipscomb; Ken Smith; Michael Oliver Day; Nick Jeffery; Richard John Mellanby
Journal:  J Vet Sci       Date:  2020-05       Impact factor: 1.672

4.  Diagnosis of post-attenuation neurological signs syndrome in a cat with refractory status epilepticus and clinical response to therapeutic plasma exchange.

Authors:  Lisa Niemann; Katrin Beckmann; Claudia Iannucci; Adriano Wang Leandro; Alessio Vigani
Journal:  JFMS Open Rep       Date:  2022-09-17

5.  Brain proton magnetic resonance spectroscopy findings in a Beagle dog with genetically confirmed Lafora disease.

Authors:  Neringa Alisauskaite; Katrin Beckmann; Matthias Dennler; Niklaus Zölch
Journal:  J Vet Intern Med       Date:  2020-05-17       Impact factor: 3.333

6.  Interictal Single-Voxel Proton Magnetic Resonance Spectroscopy of the Temporal Lobe in Dogs With Idiopathic Epilepsy.

Authors:  Agnieszka Olszewska; Martin Jürgen Schmidt; Klaus Failing; Józef Nicpoń; Przemysław Podgórski; Marcin Adam Wrzosek
Journal:  Front Vet Sci       Date:  2020-09-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.